Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
HALO: Lovaza for Hypertriglyceridemia in HIV
NCT00795717Phase 4Completed
- Sponsor
- Tufts University
- Start
- Jul 2008
- Primary completion
- Oct 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in hypertriglyceridemia comparing Lovaza with Placebo (2 arms). Primary endpoint: Change in Baseline Mean Serum Triglyceride Level at 12 weeks. Started Jul 2008; status: completed.
02
Drugs
eicosapentaenoic acid + docosahexaenoic acid
03
Conditions
hypertriglyceridemia
Beyond the preview
Go deeper on NCT00795717.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00795717.